Targeting CDK7 for ATRT Therapy
Cindy Campbell2026-02-03T18:27:11-05:00Atypical teratoid/rhabdoid tumors (ATRT) are rare, aggressive brain tumors that primarily affect very young children and have limited treatment options. Dr. Rajeev Vibhakar at the Children's Hospital of Colorado is leading research to investigate a promising new approach by targeting a critical protein—called CDK7—that ATRT tumor cells depend on to grow and survive. By blocking [...]



